These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3032215)

  • 1. Cell fusion by nasopharyngeal carcinoma-derived Epstein-Barr virus.
    Takimoto T; Sato H; Ogura H; Miyazaki T
    Arch Otolaryngol Head Neck Surg; 1987 May; 113(5):510-3. PubMed ID: 3032215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
    Takimoto T; Ogura H; Ohno S; Umeda R; Hatano M
    J Natl Cancer Inst; 1984 Sep; 73(3):711-5. PubMed ID: 6088881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marmoset lymphoblastoid cells transformed by NPC-KT-derived Epstein-Barr virus which possesses transforming and superinfecting characteristics.
    Takimoto T; Sato H; Ogura H; Ogura T; Ishikawa S; Iwawaki J
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(4):169-74. PubMed ID: 2819802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells.
    Takimoto T; Furukawa M; Hatano M; Umeda R
    Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):166-9. PubMed ID: 6324641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus lytic cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid cell line.
    Yoshizaki T; Takimoto T; Takeshita H; Tanaka S; Furukawa M; Seiki M; Sato H
    Laryngoscope; 1994 Jan; 104(1 Pt 1):91-4. PubMed ID: 8295464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).
    Takimoto T; Kamide M; Umeda R
    Arch Otorhinolaryngol; 1984; 239(1):87-92. PubMed ID: 6318711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of an Epstein-Barr virus early antigen and cell fusion].
    Furukawa M; Kamide M; Kato C; Sakashita H; Takeshita H; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 May; 92(5):722-5. PubMed ID: 2559176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the ability of cells to fuse are mediated by strains of Epstein-Barr virus.
    Takimoto T; Sato H; Ogura H; Tanaka S; Masuda K; Ishikawa S; Umeda R
    Laryngoscope; 1989 Oct; 99(10 Pt 1):1075-80. PubMed ID: 2552238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of an Epstein-Barr virus (EBV) genome-positive subline of Ramos (Ramos/NPC) following infection of Ramos with nasopharyngeal carcinoma (NPC)-derived EBV.
    Takimoto T; Sato H; Ogura H; Miyazaki T
    Auris Nasus Larynx; 1987; 14(2):87-92. PubMed ID: 2835030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of human epithelial cell lines by Epstein-Barr virus. Interaction between epithelial cell and B lymphocyte.
    Takimoto T; Morishita K; Umeda R; Ogura H; Hatano M
    ORL J Otorhinolaryngol Relat Spec; 1984; 46(4):195-201. PubMed ID: 6087238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) receptors on epithelial hybrid cells derived from nasopharyngeal carcinoma.
    Takimoto T; Tanaka S; Ishikawa S; Umeda R
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(2):69-74. PubMed ID: 2158034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The difference in tumorigenicity between Epstein-Barr virus (EBV) genome-positive and genome-negative epithelial hybrid cell lines derived from the human nasopharynx.
    Takimoto T; Sato H; Ogura H; Tanaka S; Umeda R
    Laryngoscope; 1988 Dec; 98(12):1334-8. PubMed ID: 2849005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
    Takimoto T; Sato H; Ogura H; Glaser R
    Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the DNAs of Epstein-Barr virus (EBV) derived from two EBV genome-positive epithelial/hybrid cell lines (NPC-KT and A2L/AH)].
    Takimoto T; Miyazaki T; Iwawaki J; Ishikawa S; Tanaka S; Masuda K; Yoshizaki T
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Aug; 90(8):1177-80. PubMed ID: 2824736
    [No Abstract]   [Full Text] [Related]  

  • 16. Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.
    Sato H; Takimoto T; Pagano JS; Raab-Traub N
    J Virol; 1988 Sep; 62(9):3288-94. PubMed ID: 2841481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
    Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R
    J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma.
    Takimoto T; Umeda R
    Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells.
    Takimoto T; Umeda R; Ogura H; Hatano M
    Am J Otolaryngol; 1984; 5(1):1-6. PubMed ID: 6099983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
    Glaser R; Zhang HY; Yao KT; Zhu HC; Wang FX; Li GY; Wen DS; Li YP
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9524-8. PubMed ID: 2556716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.